These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11140779)

  • 1. Opiate antagonists in children and adolescents.
    Chabane N; Leboyer M; Mouren-Simeoni MC
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I44-50. PubMed ID: 11140779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].
    Desjardins S; Doyen C; Contejean Y; Kaye K; Paubel P
    Encephale; 2009 Apr; 35(2):168-72. PubMed ID: 19393386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytics, adrenergic agents, and naltrexone.
    Riddle MA; Bernstein GA; Cook EH; Leonard HL; March JS; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):546-56. PubMed ID: 10230186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone Reduces Binge Eating and Purging in Adolescents in an Eating Disorder Program.
    Stancil SL; Adelman W; Dietz A; Abdel-Rahman S
    J Child Adolesc Psychopharmacol; 2019 Nov; 29(9):721-724. PubMed ID: 31313939
    [No Abstract]   [Full Text] [Related]  

  • 5. Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review.
    Roy A; Roy M; Deb S; Unwin G; Roy A
    J Intellect Disabil Res; 2015 Apr; 59(4):293-306. PubMed ID: 24589346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V; Van Kirk J
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sablaban IM; Sivananthan M
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):620. PubMed ID: 33146546
    [No Abstract]   [Full Text] [Related]  

  • 8. Naltrexone and communication skills in young children with autism.
    Feldman HM; Kolmen BK; Gonzaga AM
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):587-93. PubMed ID: 10230191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone in children with autism.
    Buitelaar JK; Willemsen-Swinkels S; Van Engeland H
    J Am Acad Child Adolesc Psychiatry; 1998 Aug; 37(8):800-2. PubMed ID: 9695440
    [No Abstract]   [Full Text] [Related]  

  • 10. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose naltrexone and liver function safety.
    Marrazzi MA; Wroblewski JM; Kinzie J; Luby ED
    Am J Addict; 1997; 6(1):21-9. PubMed ID: 9097868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone: new preparation. Transient preventive efficacy on alcoholic relapse.
    Prescrire Int; 1999 Feb; 8(39):9-11. PubMed ID: 10557566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?
    Good P
    Med Hypotheses; 2006; 67(3):671-2. PubMed ID: 16759815
    [No Abstract]   [Full Text] [Related]  

  • 14. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disorders.
    Raingeard I; Courtet P; Renard E; Bringer J
    Diabetes Care; 2004 Mar; 27(3):847-8. PubMed ID: 14988322
    [No Abstract]   [Full Text] [Related]  

  • 16. Naltrexone in alcohol dependence.
    Hartmann PM
    Am Fam Physician; 1997 Apr; 55(5):1877-9, 1883-4. PubMed ID: 9105212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
    Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism.
    Sinclair JD
    Alcohol Alcohol; 2001; 36(1):2-10. PubMed ID: 11139409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolved: autistic children should have a trial of naltrexone.
    Campbell M; Harris JC
    J Am Acad Child Adolesc Psychiatry; 1996 Feb; 35(2):246-9; discussion 249-51. PubMed ID: 8720635
    [No Abstract]   [Full Text] [Related]  

  • 20. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.
    Ray LA; Chin PF; Miotto K
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):13-22. PubMed ID: 20201811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.